Economic Burden Analysis of Parkinson’s Disease Patients in China

Background and Objective. Parkinson’s Disease (PD) is a progressive neurodegenerative disorder, which is prevalent in people over 65 years old. PD reduces patients’ quality of life and exerts a heavy economic burden on patients and their families. The purpose of this research is to identify the cost...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun-Xiu Yang, Lei Chen
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2017/8762939
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551581121249280
author Jun-Xiu Yang
Lei Chen
author_facet Jun-Xiu Yang
Lei Chen
author_sort Jun-Xiu Yang
collection DOAJ
description Background and Objective. Parkinson’s Disease (PD) is a progressive neurodegenerative disorder, which is prevalent in people over 65 years old. PD reduces patients’ quality of life and exerts a heavy economic burden on patients and their families. The purpose of this research is to identify the costs of PD and to evaluate the economic distribution of medical care for PD patients in China. Methods. A professional survey was administered to 116 patients with PD. Records of medical cost were reviewed. Direct and indirect costs were analyzed. The main cost-driving factors of PD were identified using multivariate regression analysis. Results. The average annual cost per PD patient in China is $3,225.94, with direct and indirect costs accounting for $2,503.46 and $722.48, respectively. Direct costs consist of $556.27 for surgery, $44.67 for appointment fees, $605.67 for prescription medication, $460.29 for hospitalization, $71.03 for auxiliary examination, $35.64 for transportation, $10.39 for special equipment, and $719.50 for formal care. The total cost is closely related to surgical treatment, dopamine agonist, and levodopa costs. Conclusion. The cost of PD patients in China is considerable and exceeds average economic capacity, especially antiparkinson medication and caring costs. This study may provide a reference for PD healthcare optimization in the future.
format Article
id doaj-art-0b2b5cd83a6847e2aac51f1f4cfda2d7
institution Kabale University
issn 2090-8083
2042-0080
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-0b2b5cd83a6847e2aac51f1f4cfda2d72025-02-03T06:00:58ZengWileyParkinson's Disease2090-80832042-00802017-01-01201710.1155/2017/87629398762939Economic Burden Analysis of Parkinson’s Disease Patients in ChinaJun-Xiu Yang0Lei Chen1Department of Neurology, Tianjin Union Medical Center, Tianjin 300121, ChinaDepartment of Neurology, Tianjin Union Medical Center, Tianjin 300121, ChinaBackground and Objective. Parkinson’s Disease (PD) is a progressive neurodegenerative disorder, which is prevalent in people over 65 years old. PD reduces patients’ quality of life and exerts a heavy economic burden on patients and their families. The purpose of this research is to identify the costs of PD and to evaluate the economic distribution of medical care for PD patients in China. Methods. A professional survey was administered to 116 patients with PD. Records of medical cost were reviewed. Direct and indirect costs were analyzed. The main cost-driving factors of PD were identified using multivariate regression analysis. Results. The average annual cost per PD patient in China is $3,225.94, with direct and indirect costs accounting for $2,503.46 and $722.48, respectively. Direct costs consist of $556.27 for surgery, $44.67 for appointment fees, $605.67 for prescription medication, $460.29 for hospitalization, $71.03 for auxiliary examination, $35.64 for transportation, $10.39 for special equipment, and $719.50 for formal care. The total cost is closely related to surgical treatment, dopamine agonist, and levodopa costs. Conclusion. The cost of PD patients in China is considerable and exceeds average economic capacity, especially antiparkinson medication and caring costs. This study may provide a reference for PD healthcare optimization in the future.http://dx.doi.org/10.1155/2017/8762939
spellingShingle Jun-Xiu Yang
Lei Chen
Economic Burden Analysis of Parkinson’s Disease Patients in China
Parkinson's Disease
title Economic Burden Analysis of Parkinson’s Disease Patients in China
title_full Economic Burden Analysis of Parkinson’s Disease Patients in China
title_fullStr Economic Burden Analysis of Parkinson’s Disease Patients in China
title_full_unstemmed Economic Burden Analysis of Parkinson’s Disease Patients in China
title_short Economic Burden Analysis of Parkinson’s Disease Patients in China
title_sort economic burden analysis of parkinson s disease patients in china
url http://dx.doi.org/10.1155/2017/8762939
work_keys_str_mv AT junxiuyang economicburdenanalysisofparkinsonsdiseasepatientsinchina
AT leichen economicburdenanalysisofparkinsonsdiseasepatientsinchina